Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION BP
Report ID | 124615 |
Drug Identification Number | 02250306 |
Brand name | CEFTRIAXONE SODIUM FOR INJECTION BP |
Common or Proper name | Ceftriaxone Sodium for Injection, BP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | CEFTRIAXONE |
Strength(s) | 2G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10 x 2g vial |
ATC code | J01DD |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-09-30 |
Estimated end date | |
Actual end date | 2021-04-05 |
Shortage status | Resolved |
Updated date | 2021-04-06 |
Company comments | Item is discontinued. |
Health Canada comments | |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.